rosiglitazone has been researched along with Genetic Predisposition in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caruso, R; Gao, F; Head, RD; Holtzman, MJ; Kaiko, GE; Kern, JT; Liu, TC; McGovern, DP; Nunez, G; Rajala, MW; Stappenbeck, TS; VanDussen, KL; Wilen, CB; Xiong, S | 1 |
Du, X; Gao, M; Li, L; Liao, J; Liu, G; Qi, Y; Wang, M; Wang, Y; Yang, H | 1 |
Bai, L; Doran, A; Faraji, F; Goldberger, N; Ha, NH; Hu, Y; Hunter, KW; Keane, T; Lee, MP; Shukla, A; Yang, HH | 1 |
Hayden, EC | 1 |
Aziz, AR; Deliard, S; Grant, SF; Zhao, J | 1 |
Auclair, M; Boccara, F; Capeau, J; Capel, E; Caron-Debarle, M; Guerci, B; Lascols, O; Vigeral, C; Vigouroux, C | 1 |
Cocca, C; Perez-Castillo, A; Pignatelli, M; Santos, A | 1 |
Chatterjee, VK; Chen, CS; Eng, C; Shaiu, CW; Teresi, RE; Waite, KA | 1 |
Benight, N; Denson, LA; Frank, SJ; Han, X; Loesch, K; Osuntokun, B | 1 |
9 other study(ies) available for rosiglitazone and Genetic Predisposition
Article | Year |
---|---|
Interaction between smoking and ATG16L1T300A triggers Paneth cell defects in Crohn's disease.
Topics: Animals; Apoptosis; Autophagy-Related Proteins; Carrier Proteins; Crohn Disease; Female; Genetic Predisposition to Disease; Humans; Male; Mice; Mice, Knockout; Mutation, Missense; Paneth Cells; PPAR gamma; Rosiglitazone; Smoking | 2018 |
Adipose tissue deficiency results in severe hyperlipidemia and atherosclerosis in the low-density lipoprotein receptor knockout mice.
Topics: Adipose Tissue; Adiposity; Animals; Atherosclerosis; Cholesterol; Diet, High-Fat; Disease Models, Animal; Genetic Predisposition to Disease; GTP-Binding Protein gamma Subunits; Heterotrimeric GTP-Binding Proteins; Hyperlipidemias; Hypolipidemic Agents; Macrophages; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Receptors, LDL; Rosiglitazone; Severity of Illness Index; Thiazolidinediones; Time Factors | 2016 |
An Integrated Genome-Wide Systems Genetics Screen for Breast Cancer Metastasis Susceptibility Genes.
Topics: Animals; Cell Adhesion Molecules; Cell Line, Tumor; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; Genome-Wide Association Study; Kruppel-Like Transcription Factors; Lung Neoplasms; Mammary Neoplasms, Animal; Mice; Mice, Inbred NZB; Mice, Transgenic; Nectins; Promyelocytic Leukemia Zinc Finger Protein; RNA Interference; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones | 2016 |
Alzheimer's tests under fire.
Topics: Age of Onset; Alzheimer Disease; Apolipoprotein C-I; Apolipoproteins E; Clinical Trials as Topic; Genetic Predisposition to Disease; Genetic Testing; Genomics; Humans; Licensure; Pharmacogenetics; Philadelphia; Rosiglitazone; Thiazolidinediones | 2008 |
Expression analyses of the genes harbored by the type 2 diabetes and pediatric BMI associated locus on 10q23.
Topics: Adipocytes; Adipogenesis; Arrhythmias, Cardiac; Body Mass Index; Cell Line; Chromans; Chromosomes, Human, Pair 10; Diabetes Mellitus, Type 2; Gene Expression Profiling; Genetic Diseases, X-Linked; Genetic Loci; Genetic Predisposition to Disease; Gigantism; Heart Defects, Congenital; Homeodomain Proteins; Humans; Hypoglycemic Agents; Insulin Resistance; Insulysin; Intellectual Disability; Kinesins; Linkage Disequilibrium; Rosiglitazone; Thiazolidinediones; Transcription Factors; Troglitazone | 2012 |
Peroxisome proliferator-activated receptor-γ mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system.
Topics: Adult; Aged; Amino Acid Sequence; Angiotensin II; Anilides; Animals; Case-Control Studies; Enzyme Activation; Female; Fibroblasts; Genetic Predisposition to Disease; HEK293 Cells; Humans; Hypertension; Inflammation Mediators; Leukocytes, Mononuclear; Lipodystrophy, Familial Partial; Male; Mitogen-Activated Protein Kinases; Molecular Sequence Data; Muscle, Smooth, Vascular; Mutation; Myocytes, Smooth Muscle; Oxidative Stress; Phenotype; PPAR gamma; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA Interference; Rosiglitazone; Severity of Illness Index; Skin; Thiazolidinediones; Transfection; Young Adult | 2013 |
Enhancement of BRCA1 gene expression by the peroxisome proliferator-activated receptor gamma in the MCF-7 breast cancer cell line.
Topics: BRCA1 Protein; Breast Neoplasms; Female; Genetic Predisposition to Disease; Humans; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors | 2003 |
Increased PTEN expression due to transcriptional activation of PPARgamma by Lovastatin and Rosiglitazone.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Dose-Response Relationship, Drug; G1 Phase; Genetic Predisposition to Disease; Germ-Line Mutation; Humans; Hypoglycemic Agents; Lovastatin; PPAR gamma; PTEN Phosphohydrolase; Rosiglitazone; Thiazolidinediones; Transcriptional Activation; Up-Regulation | 2006 |
Signal transducer and activator of transcription 5b promotes mucosal tolerance in pediatric Crohn's disease and murine colitis.
Topics: Animals; Carrier Proteins; Child; Colitis; Colon; Crohn Disease; Epithelial Cells; Female; Genetic Predisposition to Disease; Humans; Hypoglycemic Agents; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Mucous Membrane; NF-kappa B; PPAR gamma; Rosiglitazone; Signal Transduction; STAT5 Transcription Factor; Thiazolidinediones; Trinitrobenzenesulfonic Acid | 2006 |